Principal Investigator Dr. John Pagel to Brief Clinicians From Major Bone Marrow Transplant Centers on Upcoming Pivotal Trial of Iomab-B Feb 12, 2015
Actinium's Chief Medical Officer to Participate in the Next Gen Immunotherapeutics Panel at the 3rd Annual Sachs Cancer Bio Partnering & Investment Forum on February 23rd Feb 9, 2015
Actinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock Feb 6, 2015
Actinium Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock Feb 5, 2015
Actinium Engages Dr. Roland Turck, Former President, Global Specialty Medicine, Bayer Healthcare as Board Advisor Feb 4, 2015
Actinium to Participate in the Canaccord Genuity Rare Disease and Biopharma One-on-One Day on February 3rd Jan 28, 2015
